Lometrexol (DDATHF) hydrate, an antipurine antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol hydrate can further inhibit de novo purine synthesis, causing abnormal cell proliferation and apoptosis, even cell cycle arrest. Lometrexol hydrate has anticancer activity. Lometrexol hydrate also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor[1][2][3].
Molecular Weight:
461.47
Purity:
99.20
CAS Number:
[1435784-14-7]
Formula:
C21H27N5O7
Target:
Antifolate,Apoptosis,Bcl-2 Family,Caspase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
